EVO NXT | DejaVoo: Pursuing Distinct Flavor and Design, Enhancing Brand Visibility

2Firsts Events by 2FIRSTS Vincent, edited by Sophia
Apr.06.2024
EVO NXT | DejaVoo: Pursuing Distinct Flavor and Design, Enhancing Brand Visibility
DejaVoo showcases innovative e-cigarette products, including refillable options, at EVO NXT tobacco exhibition in Malaga, Spain.

At the EVO NXT tobacco exhibition held in Malaga, Spain on April 6th, e-cigarette brand DejaVoo introduced a range of innovative products, including their flagship pod system. 2FIRSTS had a discussion with DejaVoo's European business manager Steve to learn more about the brand's growth in the Spanish market.

 

Steve explained that the products showcased at the exhibition mainly include the following items: disposable e-cigarettes featuring ceramic atomizers with high efficiency and improved flavor, offering good value for money. Additionally, there are also refillable e-cigarettes, which are currently a prominent trend in the market, focusing on flavor and design aesthetics.

 

EVO NXT | DejaVoo: Pursuing Distinct Flavor and Design, Enhancing Brand Visibility
Products displayed at the DejaVoo booth | Image source: 2FIRSTS

 

Among them, the e-cigarette with FEELM MAX technology for easy pod replacement is currently the most popular product.

 

Regarding product trends in the Spanish market, Steve stated that this market is heavily influenced by the tourism industry, with consumers showing a higher preference for box-shaped e-cigarette products. There is also a certain tendency towards specific flavors.

 

DejaVoo has just entered the Spanish market, with this exhibition being its first stop, and is currently working on finalizing local agents. Regarding the core market strategy in Spain, Steve stated that DejaVoo will focus on product innovation and differentiation to meet the needs of different consumers. At the same time, they hope to find like-minded distribution partners to jointly expand the market.

 

When asked about the reasons for choosing the Spanish market, Steve mentioned that the market has relatively low entry barriers and hurdles, allowing for quick implementation and product validation. Additionally, the current regulatory environment in the Spanish market is more open, albeit somewhat ambiguous, which also means a smaller market size.

 

According to Steve, the e-cigarette market in Spain is currently quite diverse, with top brands including Lost Mary, Aroma King, SKE Crystal, and Fumot.

 

Looking ahead to the e-cigarette market in Spain in 2024, Steve believes that the market will become more consolidated, with the effects of individual brands becoming increasingly apparent. National brands are expected to become more prominent.

 

Steve stated that the e-cigarette has a harm reduction effect of 95% compared to traditional cigarettes and is a good alternative for traditional smokers. Additionally, e-cigarettes can provide a healthier experience.

 

Steve stated that DejaVoo will actively respond to the regulatory policies of the Spanish government, ensuring compliance while also focusing on protecting youth and environmental initiatives.

 

"Regulatory compliance is the baseline, and we will actively embrace it, closely monitoring it," said Steve.

 

DejaVoo's main objective in participating in this exhibition is to understand feedback from local consumers and distributors in order to better execute product strategies.

 

Steve stated that DejaVoo will continue to monitor changes in the Spanish market and constantly innovate products based on market demand in order to provide consumers with a better experience.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
South Korea Fully Reviews Nicotine-Analog and Nicotine-Free Vape Liquid Imports, With Over 99% From China and Chinese Supply-Chain Documents Under Scrutiny
Korea Customs Service has tightened import controls on nicotine-analog and nicotine-free e-cigarette liquids, placing the products under 100% document review and subjecting all e-cigarette liquid import declarations to pre-clearance ingredient analysis. As of September 20, 2026, South Korea had imported about 15 metric tons of nicotine-analog liquids, 99.99% from China, and about 316 metric tons of nicotine-free liquids, including roughly 315 metric tons, or 99.7%, from China. The measures follow South Korea's April expansion of its tobacco definition to include synthetic nicotine products and include new checks on Chinese manufacturing, transaction and export documentation.
Sep.24
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Product | JTI Introduces Fully Dissolvable PERLZ Nicotine Pearls in UK, Expands Range From 30-Pearl Dispensers to 10-Pearl Sachets
Japan Tobacco International (JTI) has introduced PERLZ nicotine pearls in the UK, expanding its oral nicotine portfolio beyond conventional nicotine pouches. The fully dissolvable, multi-layer pearls are placed under the tongue and come in Mint and Berry flavors at concentrations of 1mg/g and 2mg/g, equivalent to approximately 0.3mg and 0.5mg of nicotine per pearl. UK retailer Haypp published four 30-pearl dispenser listings on July 31, 2026, followed by three 10-pearl sachet products on August 17. The dispensers retail for £6.50, while the sachets cost £2.50.
product
Oct.12
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23